Lexicon Pharma (LXRX) reported Q1 Revenue
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.17 --0%
EPS Growth %: -600.0%
Financial Fact:
Consolidated net loss per common share, basic and diluted: -0.35
Today's EPS Names:
CCEL, FNGR, FAST, More
EPS Growth %: -600.0%
Financial Fact:
Consolidated net loss per common share, basic and diluted: -0.35
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 Revenue for the quarter came in at $21.1 million versus the consensus estimate of $9.78 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- Keybanc's Engineering & Construction 2Q26 Preview
- BofA Securities Downgrades Sylvamo Corp. (SLVM) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
